Parkinson`s Disease
Download
Report
Transcript Parkinson`s Disease
Parkinson’s
Disease
By Nik Sanyal
This
= movement disorder caused by
degeneration of dopamine pathways in
substantia nigra
Characterised
by:
TREMOR
RIGIDITY
BRADYKINESIA
+/- postural instability
Epidemiology + Risk Factors
Peak age of onset = 55-65
Men > Women
2nd most common neurodegenerative
disease after Alzheimer’s
Risk factors:
Age
Gender
Spring birth
Exposure to pesticides e.g. paraquat or Agent
Orange
Pathogenesis
Most cases = idiopathic PD. Leading to a
progressive degeneration + development of
Lewy bodies in substantia nigra.
Other pathways – mesocortical, mesolimbic +
tubero-hypophyseal
Genetics (lead to early onset):
mutations in c’some 6 = AR PD
Alpha synuclein mutation
Parkin gene
Dopamine has a role in disinhibition of motor activity
hence why reduced levels leads to dyskinesia.
Pathophysiology
Cell
death in substantia nigra (particularly
pars compacta) leads to reduced
dopamine secreting cells.
Dopamine acts to facilitate release of
inhibition and as such in PD there is
greater exertion required to initiate a
movement as there is less release of
inhibition.
Clinical features
1)
Resting tremor = usually unilateral before it
becomes generalised. It is 4-6 Hz pill-rolling.
Typically absent during activity.
2)
Rigidity = lead pipe. Cog-wheeling occurs
when lead pipe rigidity is broken up by tremor.
3)
Bradykinesia = festinant gait (slow to start +
small shuffling steps + difficult turns) Has
diminished arm swing = leads to recurrent falls.
You also get reduction in amplitude of repetitive
movements.
Other features
Progressive
decline over years
Mask-like face
Impaired swallowing – drooling, choking
on food
Cognitive decline = depression +
dementia
Quiet voice progressing to dysarthria
Micrographia (small + spidery writing)
DDx
Wilson’s
Lewy Body dementia: get visual hallucinations
CJD: Dementia + myoclonic jerking
Parkinson’s plus
Huntington’s disease
Drug-induced PD
Antipsychotics (APAT side effects: acute
dystonia, parkinsonism, akathisia, tardive
dyskinesia)
Lithium
Benign essential tremor
Rarely at rest, worse on movement
Family hx
NICE criteria for Dx
Exclude other causes
Bradykinesia + at least 1 of:
Rigidity
4-6Hz resting tremor
Postural instability
Supportive criteria:
Unilateral
Progressive nature
Asymmetry before bilateral
Response to L-Dopa
Investigations
Typically
a clinical diagnosis
Use:
Bedside: BP lying + standing, urine dip
Bloods: Genetic testing for Huntington’s or
caeruloplasmin for Wilson’s
Imaging: CT/MRI
Fail
to respond to L-Dopa
Can visualise structural defects
Special tests: DAT scan can differentiate
between drug-induced + PD.
Conservative management
Advice + explanation, consider nonphysical problems (depression, poor sleep,
dementia).
Limited time frame for meds so start when
really needed + started by neurologist!
MDT: specialist nurses, OT, SALT, psychiatrist,
GP, neurologist, dietician
Inform DVLA
REHAB
Medical management
Drugs alter the natural progression – they just improve
symptoms.
Levodopa
Is
the most effective drug.
It crosses the BBB and enters the nigrostriatal neurones
and is converted to dopamine.
Give with dopa-decarboxylase inhibitor e.g. carbidopa
to inhibit peripheral metabolism.
S/E = N+V, confusion, on-off phenomena, wearing off +
dyskinesia, hallucination
Dopamine agonists e.g. Pramipexole = good for
motor sx
1st
line in younger patients
MAO-B inhibitors = selegiline = block dopamine
breakdown. Good for motor sx.
COMT inhibitors = entacapone = inhibits peripheral
break down. S/E = hepatotoxic, N+V, confusion.
Amantadine: can be used as monotherapy in
early PD but has poor evidence base. Enhances
dopamine release.
Apomorphine can reduce off periods given as s/c
injection. S/E confusion + hallucinations
Surgical
Deep
brain stimulation
Pallidotomy involves surgical destruction
of the globus pallidus to control
dyskinesia.
Complications
Infection
Aspiration
Bed
pneumonia
sores
Poor nutrition
Falls
PD dementia
Prognosis
Slowly
progressive
Mean duration 15 years
Variable severity
Earlier age of onset = poorer prognosis
Death usually from complications e.g.
pneumonia.
Parkinson’s plus syndromes
Disorders with parkinsonism + additional
features + specific pathology.
Vascular dementia
Orthotic hypotension = multi-system atrophy
gives insomnia, somnolence, restless legs,
hallucinations. Use fludrocortisone for BP
Dementia + vertical gaze palsy= progressive
supra-nuclear palsy
Kayser-Fleischer rings = Wilson’s
Apraxic gait – communicating hydrocephalus
Good luck!
Parkinson’s
notes
http://www.patient.co.uk/doctor/parkinson
ism-and-parkinsons-disease
Extrapyramidal
exam
http://youtu.be/6PDxANv_ME8
Gait
http://youtu.be/7SyTpEdhBLw